Agenus (AGEN) EBITDA Margin (2010 - 2026)

Agenus (AGEN) posted quarterly EBITDA Margin of 44.62% for Q1 2026, up 9993.0% year-over-year from N/an in Q1 2025, and up 6.01% quarter-over-quarter from 42.09% in Q4 2025.

Agenus (AGEN) EBITDA Margin (2010 - 2026) Analysis & Trends

Agenus' EBITDA Margin history runs 17 years deep, the most recent figure standing at 44.62% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 9993.0% year-over-year to 44.62%; the TTM figure through Mar 2026 stood at 6.62% (up 10800.0% YoY), while the FY2025 annual figure was 17.66%, up 9878.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 44.62%, up from 42.09% in the prior quarter.
  • The five-year high for EBITDA Margin was 130.27% in Q4 2022, with the low at 237.28% in Q1 2023.
  • The 5-year median for EBITDA Margin is 117.41% (2024), against an average of 92.22%.
  • Peak annual rise in EBITDA Margin reached 40581 bps in 2022, while the deepest fall reached 25702 bps in 2022.
  • Agenus' EBITDA Margin stood at 130.27% in 2022, then plunged by 104 bps to 5.01% in 2023, then tumbled by 1825 bps to 96.49% in 2024, then jumped by 144 bps to 42.09% in 2025, then gained by 6 bps to 44.62% in 2026.
  • Business Quant data shows AGEN's EBITDA Margin at 44.62% in Q1 2026, 42.09% in Q4 2025, and 15.03% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.15%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 31.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.06%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,569,866.34%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.75%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 17.93%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.36%
10 Agenus 311.95 Mn 286.43 Mn 34.52 Mn 32.72%

Historic Data

Download Data
DateValue
Jun 30, 2026 32.72%
Mar 31, 2026 44.62%
Dec 31, 2025 42.09%
Sep 30, 2025 -15.03%
Jun 30, 2025 -65.05%
Mar 31, 2025 -55.31%
Dec 31, 2024 -96.49%
Sep 30, 2024 -125.45%
Jun 30, 2024 -128.43%
Mar 31, 2024 -117.41%
Dec 31, 2023 -5.01%
Sep 30, 2023 -190.59%
Jun 30, 2023 -216.11%
Mar 31, 2023 -237.28%
Dec 31, 2022 130.27%
Sep 30, 2022 -182.88%
Jun 30, 2022 -212.96%
Mar 31, 2022 -136.70%
Dec 31, 2021 -266.66%
Sep 30, 2021 74.14%